We identified ligands and signaling pathways that have implicated in IBD, such as interleukin-1β (IL-1β), supporting the validity of the approach, along with unexpected ligands, such as granzyme B, which may play previously unappreciated roles in IBD. This evidence concerns the gene GZMB and inflammatory bowel disease.